Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06544551
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Current clinical practices has shown promising prospects of the therapy strategy of interferon combined with nucleostides in patients with chronic hepatitis B but the safety and efficacy has not been fully studied This study is aimed to exploit the safety and efficacy of the study drug Peginterferon Alfacon-2 injection with nucleostide NAs Tenofovir alafenamide Fumarate Tablets TAF in the patients with hepatitis B virus infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None